文献速递生殖医学

POSEIDON分类低预后患者颗粒细胞线粒体与代谢异常研究

Mitochondria-related changes and metabolic dysfunction in low prognosis patients under the POSEIDON classification.
PubMed 文献 · Hum Reprod · 2021-01-01

该研究纳入119例接受IVF的不孕女性,按POSEIDON分层比较颗粒细胞线粒体形态、mtDNA拷贝数、膜电位、ROS及代谢。发现低预后组线粒体形态受损、活性与代谢下降,且年龄与卵巢储备功能对线粒体含量和功能呈 divergent 影响。

要点

  • 低预后组颗粒细胞线粒体形态受损,DOR患者损伤更明显。
  • 低预后组mtDNA拷贝数与年龄显著负相关(β=-0.373,P=0.005)。
  • 低预后组线粒体活性与细胞代谢降低,DOR人群下降最明显。

核心结论

  • 低预后IVF患者颗粒细胞存在明显线粒体异常,年龄与卵巢储备功能对线粒体含量和功能呈 divergent 影响。

研究设计与样本

  • 研究纳入2020年9月至2021年2月接受IVF的119例不孕女性颗粒细胞样本,按POSEIDON分层分为6组(C1、C2、G1、G2、G3、G4)。

主要发现

  • 低预后年轻组(G1、G3)线粒体呈氧化应激表型(圆形、空泡化、肿胀伴基质密度降低)。
  • 低预后高龄组(G2、G4)线粒体呈典型老化特征(形状不规则、基质密度不均、嵴呈索条状)。
  • DOR患者(G3、G4)线粒体损伤程度更明显,无论年龄。
  • 低预后组mtDNA拷贝数与年龄显著负相关(β=-0.373,P=0.005)。
  • 低预后年轻组mtDNA拷贝数与AMH评分负相关(β=-0.639,P=0.049),高龄组正相关(β=0.505,P=0.039)。

关键数值与推荐

  • 低预后组线粒体膜电位和ROS显著降低,糖酵解与OXPHOS均下降,DOR人群下降最明显。
  • 正常预后高龄女性(C2)颗粒细胞代谢从OXPHOS转向无氧糖酵解。

临床怎么用

  • 线粒体异常与IVF低预后密切相关,补充功能性线粒体含量或改善线粒体功能可能改善低预后患者临床结局,尤其DOR人群。

局限性

  • 因原代颗粒细胞收集和培养困难,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the relationship between mitochondria of granulosa cells (GCs) and age and ovarian function in the patients under the POSEIDON classification? SUMMARY ANSWER: Our results revealed obvious abnormal mitochondrial-related changes in low prognosis IVF population, where age and the function of ovarian reserve exerted a divergent effect on mitochondrial content and function. WHAT IS KNOWN ALREADY: Mitochondria have an important role in the cross-talk between GCs and oocytes. However, factors affecting mitochondria of GCs and related mechanisms are still poorly understood. STUDY DESIGN, SIZE, DURATION: GCs samples were obtained from 119 infertile women undergoing IVF from September 2020 to February 2021. Six groups were investigated by the POSEIDON stratification: young with normal prognosis (C1), aging with normal prognosis (C2), young and low prognosis group with normal ovarian reserve (NOR) (G1), aging and low prognosis group with NOR (G2), young and low prognosis group with diminished ovarian reserve (DOR) (G3), and aging and low prognosis group with DOR (G4). PARTICIPANTS/MATERIALS, SETTING, METHODS: The morphology of GC mitochondria was observed by transmission electron microscopy. MtDNA copy number and mitochondrial replication-related genes were detected by real-time quantitative PCR (qPCR). Mitochondrial membrane potential (MMP) and cytosolic reactive oxygen species (ROS) were detected by confocal microscopy. Cellular glycolysis and aerobic respiratory capacity were analyzed by Seahorse XFe96 Analyzer, and related gene expression and protein levels were assessed by qPCR and Western blot. MAIN RESULTS AND THE ROLE OF CHANCE: Compared to the normal prognosis groups, mitochondrial morphology was impaired in the low prognosis groups, where the young groups (G1, G3) with low prognosis showed phenotypes undergoing oxidative stress (round, vacuolated, swollen with decreased matrix density) and the aging groups (G2, G4) revealed typical aging characteristics (an irregular shape with heterogeneous matrix density and cord-like cristae). Additionally, the degree of corresponding change and damage was more obvious in patients with DOR (G3, G4) regardless of age. For mitochondrial content, the mtDNA copy number in GCs was significantly negatively correlated with age in the low prognosis groups (β = -0.373, P = 0.005). Interestingly, the relationship between mtDNA copy number and anti-Mullerian hormone score differed between the two age groups with low prognosis, with a negative correlation in the young groups (β = -0.639, P = 0.049) and a positive correlation in the aging groups (β = 0.505, P = 0.039). In addition, significantly reduced mitochondrial activity (MMP, ROS) and cell metabolism (both glycolysis and OXPHOS) were observed in the low prognosis groups, with the most obvious decrease being observed in the DOR population. However, the metabolism of the GCs in normal prognosis aging women (C2) shifted from OXPHOS to anaerobic glycolysis. LIMITATIONS, REASONS FOR CAUTION: Owing to the difficulties involved in primary GC collection and culture, the sample size was limited. WIDER IMPLICATIONS OF THE FINDINGS: Mitochondrial abnormality is closely linked to the low prognostic outcome in IVF patients. Supplementing the functional mitochondrial content or improving mitochondrial function by autologous mitochondrial transfer or mitochondrial-related regulating drugs may help improve the clinical outcomes in patients with a low prognosis, especially for those with DOR. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Natural Science Foundation of China (No. 21737001), the Peking University Clinical Medicine + X Youth Project (PKU2020LCXQ011), the Research and Development Program of Peking University People's Hospital (No. RDH2017-03; No. RDX2019-06) and the Application of Clinical Features of Capital Special Subject (Z171100001017130). There were no competing interests. TRIAL REGISTRATION NUMBER: This study was registered with the Chinese Clinical Trial Register (Clinical Trial Number: ChiCTR2100045531).

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Jiang Z, Shi C, Han H, et al. Mitochondria-related changes and metabolic dysfunction in low prognosis patients under the POSEIDON classification. Hum Reprod. 2021. PMID: 34545401. doi:10.1093/humrep/deab203

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。